CPT code 85097 represents the professional interpretation of a smear prepared from a bone marrow sample, typically performed by a pathologist. This diagnostic pathology service is critical for identifying hematologic disorders such as anemias, leukemias, and marrow infiltrative processes, making it an important code across inpatient and outpatient laboratory settings nationwide. Recognizing how 85097 is billed and reimbursed affects laboratory workflow, clinical documentation, and payer relations.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for bone marrow smear interpretation, common billing considerations, and benchmarks where available. The publication outlines the service setting and clinical implications, summarizes common modifiers and administrative practices associated with pathology interpretation services, and identifies gaps in available data.

This summary provides a national perspective on the role of 85097 in diagnostic pathways, the stakeholders responsible for reporting the service, and the operational touchpoints that influence billing and coding accuracy. Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.